Phase II Trial of Cisplatin and Irinotecan in Patients With Suboptimally Debulked, Incompletely Responding Ovarian Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Irinotecan
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 21 Jun 2013 Biomarkers information updated
- 03 Feb 2010 Actual end date (October 2001) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.